Related Experiment Videos
Contrasting B cell- and T cell-based protective vaccines.
Vincent A A Jansen1, Hester Korthals Altes, Georg A Funk
1School of Biological Sciences, Royal Holloway-University of London, Egham, Surrey TW20 0EX, UK. vincent.jansen@rhul.ac.uk
Journal of Theoretical Biology
|February 22, 2005
Summary
T cell vaccines may fail against low-dose pathogen exposure. Mathematical modeling reveals that T cell responses require impractically high effector cell numbers to prevent infection at low antigen doses, limiting vaccine efficacy.
Area of Science:
- Immunology
- Mathematical Biology
- Vaccinology
Background:
- Significant research focuses on developing T cell-based vaccines to combat infectious diseases like HIV.
- T cell responses involve the formation of effector cells from precursors, contrasting with near-immediate humoral responses.
Purpose of the Study:
- To investigate the potential for developing effective T cell-based vaccines.
- To model the dynamics of early-stage infection and immune responses, comparing humoral and T cell immunity.
Main Methods:
- Utilized a mathematical model to simulate pathogen and immune system dynamics during early infection.
- Compared the efficacy of near-immediate humoral responses with T cell responses requiring effector cell formation.
Main Results:
- A threshold of effector cells is required for near-immediate responses to prevent infection.
- For T cell vaccines, this threshold increases with antigen exposure, becoming impractically high at low initial doses.
- T cell vaccines may be effective against high-dose exposures but less so against low-dose exposures.
Conclusions:
- The efficacy of T cell-based vaccines may be limited, particularly in scenarios involving low initial pathogen doses.
- Mathematical modeling highlights critical factors influencing T cell vaccine effectiveness against varying exposure levels.